Therapeutic potential of synthetic triterpenoids in neuroblastoma.
Sun
Shi-Yong
SY
Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. ssun@emory.edu <ssun@emory.edu>
D000818:Animals; D017209:Apoptosis; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D002453:Cell Cycle / Q000187:drug effects*; D045744:Cell Line, Tumor; D002626:Chemistry, Pharmaceutical / Q000379:methods; D003600:Cytosol / Q000378:metabolism; D006801:Humans; D020128:Inhibitory Concentration 50; D008928:Mitochondria / Q000378:metabolism; D009447:Neuroblastoma / Q000188:drug therapy* / Q000378:metabolism*; D009828:Oleanolic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D021381:Protein Transport; D013729:Terpenes / Q000737:chemistry
C116817:2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid; D013729:Terpenes; D009828:Oleanolic Acid